Dechra Pharmaceuticals Share Price (DPH)
| Bid price | 713.00 | Open price | 715.50 |
|---|---|---|---|
| Ask price | 716.00 | Prev close | 723.00 |
| High price | 719.00 | Spread | 0.42% |
| Low price | 713.00 | Volume | 7,089 |
Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades and FREE Dechra Pharmaceuticals company fundamentals, market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.
Dechra Pharmaceuticals Share Price Chart
Register now for FREE Dechra Pharmaceuticals share price charts
Dechra Pharmaceuticals Share Price Information
| Name | Dechra Pharmaceuticals | Epic | DPH |
|---|---|---|---|
| Activites | Services accounted for 85% of fiscal 2008 revenues and Pharmaceuticals, 15% | Reuters | DPH.L |
| ISIN | GB0009633180 | Google Finance | LON:DPH |
| DPH Share Price (p) | 714.50 | Prev. Share Price (p) | 723.00 |
|---|---|---|---|
| Shares in Issue (m) | 87 | Market Cap (£m) | 524 |
| PE Ratio (x) | 31.05 | Div per share (p) | 8.50 |
| Div yield (%) | 2.02 | Div cover (x) | |
| EPS (p) | 15.60 | PEG | 1.27 |
Register now for FREE Dechra Pharmaceuticals company fundamentals
Dechra Pharmaceuticals Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 26/02/2013 | BUY | Tony Griffin | ED | 8,000 |
| 26/02/2013 | BUY | Julian Heslop | NED | 5,000 |
| 26/02/2013 | BUY | Ishbel Macpherson | NED | 2,897 |
| 24/12/2012 | SELL | Ed Torr | ED | 50,000 |
| 20/12/2012 | EXR | Ed Torr | ED | 1,785 |
Dechra Pharmaceuticals Company News
Dechra revenues up
Dechra Pharmaceuticals' group revenue for the three months to the end of March was 14.6% ahead of last year - 13.7% up at constant currency. For the nine months to the end of March, group revenue increased by 18.4% over the corresponding period in the prior year - 19.8% at constant currency....
Interim Management Statement
/* */ RNS Number : 1780E Dechra Pharmaceuticals PLC 08 May 2013 Issued by TooleyStreet Communications Date: Wednesday, 8 May 2013 Dechra ® Pharmaceuticals PLC Interim Management Statement Dechra...
More Dechra Pharmaceuticals Company News >>
Register now for FREE Dechra Pharmaceuticals company news
Dechra Pharmaceuticals Share Price Discussions
A really dreary share (DPH)
A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p...
Register now for FREE Dechra Pharmaceuticals share price discussions